Financial Advocates Investment Management Gsk PLC Transaction History

Financial Advocates Investment Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$42.05 - $47.77 $217,440 - $247,018	-5,171 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$40.23 - $47.74 $11,425 - $13,558	-284 Reduced 5.21%	5,171 $225,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $101,671 - $118,485	2,615 Added 92.08%	5,455 $240,000
Q3 2021 Nov 04, 2021	BUY	$38.79 - $43.16 $44,143 - $49,116	1,138 Added 66.86%	2,840 $222,000
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $4,800 - $5,421	-127 Reduced 6.94%	1,702 $66,000
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $72,702 - $78,080	1,829 New	1,829 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

Stay updated on Financial Advocates Investment Management with notifications on news.